These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5572748)

  • 21. The fifth component of the guinea pig complement system. I. Purification and characterization.
    Cook CT; Shin HS; Mayer MM; Laudenslayer KA
    J Immunol; 1971 Feb; 106(2):467-72. PubMed ID: 5545152
    [No Abstract]   [Full Text] [Related]  

  • 22. Isolation and characterization of C4-synthesizing cells from guinea-pig spleen.
    Ilgen CL; Bossen EH; Rowlands DT; Burkholder PM
    Immunology; 1974 Mar; 26(3):659-65. PubMed ID: 4604643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the antigenic properties of complement. I. Demonstration of agglutinating antibodies against guinea pig complement fixed on sensitized sheep erythrocytes.
    KLEIN PG; BURKHOLDER PM
    J Exp Med; 1960 Jan; 111(1):93-106. PubMed ID: 14409702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The C1-inactivator of guinea pig serum: titration, purification and characterization of the inactivator].
    Opferkuch W; Loos M; Ringelmann R
    Z Med Mikrobiol Immunol; 1971; 156(2):194-207. PubMed ID: 4995249
    [No Abstract]   [Full Text] [Related]  

  • 25. Isolation and purification of the fourth component of guinea-pig complement.
    Chan PC; Cebra JJ
    Immunochemistry; 1968 Jan; 5(1):17-22. PubMed ID: 5647092
    [No Abstract]   [Full Text] [Related]  

  • 26. The first component of guinea pig complement: hemolytic assays with EA, EAC4 and with rat and guinea pig late acting components.
    Opferkuch W; Rapp HJ; Colten HR; Borsos T
    Immunochemistry; 1971 Jun; 8(6):517-23. PubMed ID: 4997463
    [No Abstract]   [Full Text] [Related]  

  • 27. Highlights of complement research during the past twenty-five years.
    Mayer MM
    Immunochemistry; 1970 May; 7(5):485-96. PubMed ID: 4920409
    [No Abstract]   [Full Text] [Related]  

  • 28. The first component of complement in serum: evidence for a hitherto unrecognized factor in C1 necessary for internal activation.
    Loos M; Borsos T; Rapp HJ
    J Immunol; 1973 Jan; 110(1):205-12. PubMed ID: 4685401
    [No Abstract]   [Full Text] [Related]  

  • 29. COMPONENTS OF GUINEA PIG COMPLEMENT. I. SEPARATION OF A SERUM FRACTION ESSENTIAL FOR IMMUNE HEMOLYSIS AND IMMUNE ADHERENCE.
    NISHIOKA K; LINSCOTT WD
    J Exp Med; 1963 Nov; 118(5):767-93. PubMed ID: 14087621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.
    Ruddy S; Austen KF
    J Immunol; 1969 Mar; 102(3):533-43. PubMed ID: 5813010
    [No Abstract]   [Full Text] [Related]  

  • 31. Sheep serum complement sensitisation of sheep erythrocyte-rabbit antibody complexes for haemolysis by guinea-pig complement plus EDTA or Mg2+-EGTA.
    Jonas W; Stankiewicz M
    Arch Immunol Ther Exp (Warsz); 1986; 34(4):451-60. PubMed ID: 3099725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guinea pig complement: two active forms of first component.
    Hoffmann LG
    Science; 1968 Jan; 159(3812):322-3. PubMed ID: 4169049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A factor in guinea-pig serum with accelerating effect on immune immobilization of Treponema pallidum (IAF). Isolation, purification and differentiation from the known haemolytic complement components and from lysozyme.
    Müller F; Segerling M
    Immunology; 1974 Jul; 27(1):33-41. PubMed ID: 4604004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on the antigenic properties of complement. II. Analysis of specific agglutinins against certain components of guinea pig complement fixed on sensitized sheep erythrocytes.
    KLEIN PG; BURKHOLDER PM
    J Exp Med; 1960 Jan; 111(1):107-17. PubMed ID: 14409703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics of bovine complement. II. Properties of the lytic intermediate.
    Fong JS; Muschel LH; Good RA
    J Immunol; 1971 Jul; 107(1):34-40. PubMed ID: 4997115
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes.
    Kay AB
    Clin Exp Immunol; 1970 Nov; 7(5):723-37. PubMed ID: 4992784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of bovine complement. I. Formation of a lytic intermediate.
    Fong JS; Muschel LH; Good RA
    J Immunol; 1971 Jul; 107(1):28-33. PubMed ID: 5091959
    [No Abstract]   [Full Text] [Related]  

  • 39. Antigenic relationship between the fourth component of human and guinea pig complement.
    Ohanian SH; Borsos T
    J Immunol; 1975 Jan; 114(1 Pt 1):161-4. PubMed ID: 46239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A receptor for the third component of complement in the human renal glomerulus.
    Gelfand MC; Frank MM; Green I
    J Exp Med; 1975 Oct; 142(4):1029-34. PubMed ID: 1176888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.